Opiate physical dependence and N-methyl-D-aspartate receptors

European Journal of Pharmacology

Volumn 500, Issue 1-3 SPEC. ISS., 2004, Pages 121-128

  Noda, Yukihiro ^a   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

N methyl d aspartate (NMDA) receptor; Ontogeny; Opiate; Physical dependence; Signal cascade

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; 5,7 DICHLOROKYNURENIC ACID; ANTISENSE OLIGONUCLEOTIDE; BUTORPHANOL; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DEXTROMETHORPHAN; DIZOCILPINE; GLUTAMIC ACID; KETAMINE; MESSENGER RNA; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; OPIATE; PROTEIN C FOS; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN SUBUNIT;

ANIMAL BEHAVIOR; BRAIN REGION; CONCENTRATION (PARAMETERS); DRUG DEPENDENCE; DRUG EFFICACY; ELECTROPORATION; EXTRACELLULAR SPACE; MOUSE; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; ONTOGENY; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVIEW; SIGNAL TRANSDUCTION; WITHDRAWAL SYNDROME;

ANIMALS; ANIMALS, NEWBORN; HUMANS; INFANT, NEWBORN; MORPHINE; MORPHINE DEPENDENCE; NARCOTIC ANTAGONISTS; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 4644244793     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.017     Document Type: Review

References (96)

1. G.K. Aghajanian, J.H. Kogan, and B. Moghaddam Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study Brain Res. 636 1994 126 130
2. G.A. Barr, and S. Wang Tolerance and withdrawal to chronic morphine treatment in the week-old rat pup Eur. J. Pharmacol. 215 1992 35 42
3. G.A. Barr, A. Zmitrovich, A.S. Hamowy, P.Y. Liu, S. Wang, and D.E. Hutchings Neonatal withdrawal following pre-and postnatal exposure to methadone in the rat Pharmacol. Biochem. Behav. 60 1998 97 104
4. A.M. Beckmann, I. Matsumoto, and P.A. Wilce Immediate early gene expression during morphine withdrawal Neuropharmacology 34 1995 1183 1189
5. J.A. Bell, and C.L. Beglan Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat Eur. J. Pharmacol. 294 1995 297 301
6. J.A. Bell, and C.L. Beglan MK-801 blocks the expression but not the development of tolerance to morphine in the isolated spinal cord of the neonatal rat Eur. J. Pharmacol. 294 1995 89 296
7. A.Y. Bespalov, R.L. Balster, and P.M. Beardsley N-methyl-d-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats J. Pharmacol. Exp. Ther. 290 1999 20 27
8. W.K. Bickel, M.L. Stitzer, I.A. Liebson, and G.E. Bigelow Acute physical dependence in man: effects of naloxone after brief morphine exposure J. Pharmacol. Exp. Ther. 244 1988 126 132
9. A. Bisaga, P. Gianelli, and P. Popik Opiate withdrawal with dextromethorphan Am. J. Psychiatry 154 1997 584
10. A. Bisaga, P. Popik, A.Y. Bespalov, and W. Danysz Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders Exp. Opin. Invest. Drugs 9 2000 2233 2248
11. A. Bisaga, S.D. Comer, A.S. Ward, P. Popik, H.D. Kleber, and M.W. Fischman The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans Psychopharmacology 157 2001 1 10
12. J. Bläsig, A. Herz, K. Reinhold, and S. Zieglänsberger Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats Psychopharmacology 33 1973 19 38
13. L.J. Bristow, J.E. Hogg, and P.H. Hutson Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats Neuropharmacology 36 1997 241 250
14. J.J. Buccafusco Inhibition of the morphine withdrawal syndrome by a novel muscarinic antagonist (4-DAMP) Life Sci. 48 1991 749 756
15. J.J. Buccafusco Neuropharmacological and behavioral actions of clonidine: interactions with central neurotransmitters Int. Rev. Neurobiol. 33 1992 55 107
16. S.L. Cappendijk, R. de Vries, and M.R. Dzoljic Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice Eur. Neuropsychopharmacol. 3 1993 111 116
17. Q. Chen, and A. Reiner Cellular distribution of the NMDA receptor NR2A/2B subunits in the rat striatum Brain Res. 743 1996 346 352
18. A.W. Dunah, R.P. Yasuda, J. Luo, Y. Wang, K.L. Prybylowski, and B.B. Wolfe Biochemical studies of the structure and function of the N-methyl-d-aspartate subtype of glutamate receptors Mol. Neurobiol. 19 1999 151 179
19. N.B. Eddy, H. Halbach, H. Isbell, and M.H. Seevers Drug dependence: its significance and characteristics Bull. WHO 32 1965 721 733
20. G.H. Fan, L.Z. Wang, H.C. Qiu, L. Ma, and G. Pei Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence Mol. Pharmacol. 56 1999 39 45
21. Y.Z. Feng, T. Zhang, R.W. Rockhold, and I.K. Ho Increased locus coerulus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat Neurochem. Res. 20 1995 745 751
22. P. Gonzalez, P. Cabello, A. Germany, B. Norris, and E. Contreras Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists Eur. J. Pharmacol. 332 1997 257 262
23. A.M. Graybiel, R. Moratalla, and H.A. Robertson Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum Proc. Natl. Acad. Sci. U. S. A. 7 1990 6912 6916
24. M.M. Hamdy, T. Mamiya, Y. Noda, M. Sayed, A. Assi, A. Gomaa, K. Yamada, and T. Nabeshima A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice Behav. Brain Res. 118 2000 85 93
25. 2+/calmodulin-dependent signal cascade Behav. Brain Res. 152 2004 263 270
26. G.C. Harris, and G.A. Aston-Jones Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome Nature 371 1994 155 157
27. B.H. Herman, F. Vocci, and P. Bridge The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal, medication development issues for opiate addiction Neuropsychopharmacology 13 1995 269 293
28. G.A. Higgins, P. Nguyen, and E.M. Sellers The NMDA antagonist dizocilpine (MK-801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal Life Sci. 50 1992 PL167 PL172
29. M. Inoue, M. Mishina, and H. Ueda Locus-specific rescue of GluRε1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence J. Neurosci. 23 2003 6529 6536
30. C.E. Inturrisi Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence Semin. Neurosci. 9 1997 110 119
31. H. Isbell, and H.F. Fraser Actions and addiction liabilities of dromoran derivatives in man J. Pharmacol. Exp. Ther. 106 1953 524 530
32. J.H. Jaffe Drug addiction of drug abuse A.G. Gilman T.W. Rall A.S. Nies P. Taylor 8th Goodman and Gilman's the Pharmacological Basis of Therapeutics 1990 Pergamon Press New York 22 573
33. K.L. Jones, and G.A. Barr Ontogeny of morphine withdrawal in the rat Behav. Neurosci. 109 1995 1189 1198
34. K.L. Jones, and G.A. Barr Opiate withdrawal in the fetal rat: a behavioral profile Pharmacol. Biochem. Behav. 66 2000 419 424
35. Y. Kiyama, T. Manabe, K. Sakimura, F. Kawakami, H. Mori, and M. Mishina Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor ε1 subunit J. Neurosci. 18 1998 6704 6712
36. H. Koyuncuoglu The treatment with dextromethorphan of heroin addicts N. Loimer R. Schmid A. Springer Drug Addiction and AIDS 1991 Springer Vienna 320 329
37. H. Koyuncuoglu, and B. Saydam The treatment of heroin addicts with dextromethorphan. A double-blind comparison of dextromethorphan with chlorpromazine Int. J. Clin. Pharmacol. Ther. 28 1990 147 152
38. H. Koyuncuoglu, M. Gungor, H. Sagduyu, and F. Aricioglu Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats Pharmacol. Biochem. Behav. 35 1990 829 832
39. H. Koyuncuoglu, Y. Dizdar, F. Aricioglu, and U. Sayin Effects of MK 801 on morphine physical dependence: attenuation and intensification Pharmacol. Biochem. Behav. 43 1992 487 490
40. T. Kutsuwada, N. Kashiwabuchi, H. Mori, K. Sakimura, E. Kushiya, K. Araki, H. Meguro, H. Masaki, T. Kumanishi, M. Arakawa, and M. Mishina Molecular diversity of the NMDA receptor channel Nature 358 1992 36 41
41. G.B. Landwehrmeyer, D.G. Standaert, CM. Testa, J.B. Penney Jr., and A.B. Young NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum J. Neurosci. 15 1995 5297 5307
42. 2+/calmodulin-dependent protein kinase II alpha during chronic morphine exposure Neuroscience 123 2004 769 775
43. 2+/ calmodulin dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: differential regulation of α and β isoforms Mol. Pharmacol. 55 1999 557 563
44. L. Lu, S. Zeng, D. Liu, and X. Ceng Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats Neurosci. Lett. 291 2000 191 195
45. R. Maldonado Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence Neurosci. Biobehav. Rev. 21 1997 91 104
46. J. Mao NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity Brain Res. Rev. 30 1999 289 304
47. D.J. Mayer, J. Mao, J. Holt, and D.D. Price Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions Proc. Natl. Acad. Sci. U. S. A. 96 1999 7731 7736
48. C.J. McBain, and M.L. Mayer N-methyl-d-aspartic acid receptor structure and function Physiol. Rev. 74 1994 723 760
49. H. Meguro, H. Mori, K. Araki, E. Kushiya, T. Kutsuwada, M. Yamazaki, T. Kumanishi, M. Arakawa, K. Sakimura, and M. Mishina Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNA Nature 357 1992 70 74
50. Y. Miyamoto, K. Yamada, Y. Noda, H. Mori, M. Mishina, and T. Nabeshima Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor ε1 subunit J. Neurosci. 21 2001 750 757
51. Y. Miyamoto, K. Yamada, T. Nagai, H. Mori, M. Mishina, H. Furukawa, Y. Noda, and T. Nabeshima Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor ε1 subunit Eur. J. Neurosci. 19 2004 151 158
52. H. Monyer, R. Sprengel, R. Schoepfer, A. Herb, M. Higuchi, H. Lomeli, N. Burnashev, B. Sakmann, and P.H. Seeberg Heteromeric NMDA receptors: molecular and functional distinction of subtypes Science 256 1992 1217 1221
53. E.J. Nestler, B.T. Hope, and K.L. Widnell Drug addiction a model for the molecular basis of neural plasticity Neuron 11 1993 995 1006
54. S. Ozawa, H. Kamiya, and K. Tsuzuki Glutamate receptors in the mammalian central nervous system Prog. Neurobiol. 54 1998 581 618
55. P. Popik, and W. Danysz Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-d-aspartate receptor antagonist, memantine J. Pharmacol. Exp. Ther. 289 1997 854 865
56. P. Popik, and P. Skolnick The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence Pharmacol. Biochem. Behav. 53 1996 791 797
57. P. Popik, J. Mamezarz, M. Fraczek, M. Widla, M. Hesselink, and W. Danysz Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonist Neuropharmacology 37 1998 1033 1042
58. E. Pothos, P. Rada, G.P. Mark, and B.G. Hoebel Dopamine microdialysis in the nucleus accumbens during acute and chronic, naloxone-precipitated withdrawal and clonidine treatment Brain Res. 566 1991 348 350
59. P. Rada, E. Pothos, G.P. Mark, and B.G. Hoebel Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine Brain Res. 561 1991 354 356
60. K. Rasmussen The role of the locus coeruleus and N-methyl-d-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal Neuropsychopharmacology 13 1995 295 300
61. K. Rasmussen, R.W. Fuller, M.E. Stockton, K.W. Perry, R.M. Swinford, and P.L. Ornstein NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal Eur. J. Pharmacol. 197 1991 9 16
62. X. Ren, Y. Noda, T. Mamiya, T. Nagai, and T. Nabeshima A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance linked to the extracellular signal-regulated protein kinase Behav. Brain Res. 152 2004 243 250
63. M.I. Rosen, T.J. McMahon, F.A. Hameedi, H.R. Pearsall, S.W. Woods, M.J. Kreek, and T.R. Kosten Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal J. Pharmacol. Exp. Ther. 276 1996 1128 1135
64. M.I. Rosen, T.J. McMahon, S.W. Woods, H.R. Pearsall, and T.R. Kosten A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal Eur. J. Pharmacol. 307 1996 251 257
65. K. Sakimura, T. Kutsuwada, I. Ito, T. Manabe, C. Takayama, E. Kushiya, T. Yagi, S. Aizawa, Y. Inoue, H. Sugiyama, and M. Mishina Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit Nature 373 1995 151 155
66. S. Schulz, and V. Hollt Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo Eur. J. Neurosci. 10 1998 1196 1201
67. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases Science 252 1991 1427 1430
68. G.R. Siggins, G. Martin, M. Roberto, Z. Nie, S. Madamba, and L. De Lecea Glutamatergic transmission in opiate and alcohol dependence Ann. N.Y. Acad. Sci. 1003 2003 196 211
69. D.G. Standaert, G.B. Landwehrmeyer, J.A. Kerner, J.B. Penney Jr., and A.B. Young Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus Mol. Brain Res. 42 1996 89 102
70. R.L. Stornetta, F.E. Norton, and P.G. Guyenet Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats Brain Res. 624 1993 19 28
71. S. Tanganelli, T. Antonelli, M. Morari, C. Bianchi, and L. Beani Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs Neurosci. Lett. 122 1991 270 272
72. S.R. Thornton, and F.L. Smith Characterization of neonatal rat fentanyl tolerance and dependence J. Pharmacol. Exp. Ther. 281 1997 514 521
73. S.R. Thornton, A.F. Wang, and F.L. Smith Characterization of neonatal rat morphine tolerance and dependence Eur. J. Pharmacol. 340 1997 161 167
74. H.K. Tjon Tien Ril, T.J. De Vries, G. Wardeh, F. Hogenboom, A.H. Mulder, and A.N. Schoffelmeer Long-lasting reciprocal changes in striatal dopamine and acetylcholine release upon morphine withdrawal Eur. J. Pharmacol. 235 1993 321 322
75. S. Tokuyama, H. Wakabayashi, and I.K. Ho Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome Eur. J. Pharmacol. 295 1996 123 129
76. S. Tokuyama, H. Zhu, H. Wakabayashi, Y.Z. Feng, and I.K. Ho The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats J. Biomed. Sci. 5 1998 45 53
77. S. Tokuyama, H. Zhu, S. Oh, I.K. Ho, and T. Yamamoto Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids Neurochem. Int. 39 2001 103 109
78. K.A. Trujillo Effects of non-competitive N-methyl-d-aspartate receptor antagonists on opiate tolerance and physical dependence Neuropsychopharmacology 13 1995 301 307
79. K.A. Trujillo Cellular and molecular mechanisms of opioid tolerance and dependence: progress and pitfalls Pain Forum 8 1999 29 33
80. K.A. Trujillo Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? a review of preclinical studies Psychopharmacology 151 2000 121 141
81. K.A. Trujillo, and H. Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science 251 1991 85 87
82. K.A. Trujillo, and H. Akil Does MK-801 block naloxone-precipitated opiate withdrawal? Abstr.-Soc. Neurosci. 19 1993 1246
83. K.A. Trujillo, and H. Akil Excitatory amino acids and drugs of abuse: a role for N-methyl-d-aspartate receptors in drug tolerance, sensitization and physical dependence Drug Alcohol Depend. 38 1995 139 154
84. E.J. Van Bockstaele, A.S. Menko, and G. Drolet Neuroadaptive responses in brainstem noradrenergic nuclei following chronic morphine exposure Mol. Neurobiol. 23 2001 155 171
85. R.I. Wang, R.L. Wiesen, S. Lamid, and B.L. Roh Rating the presence and severity of opiate dependence Clin. Pharmacol. Ther. 16 1974 653 658
86. A. Wikler, H.F. Fraser, and H. Isbell N-Allylomorphine: effects of single doses and precipitation of acute "abstinence syndromes" during addiction to morphine, methadone or heroin in man (postaddicts) J. Pharmacol. Exp. Ther. 109 1953 8 20
87. R.T. Windh, P.J. Little, and C.M. Kuhn The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies J. Pharmacol. Exp. Ther. 273 1995 1361 1374
88. E.H.F. Wong, J.A. Kemp, T. Priestley, A.R. Knight, G.N. Woodruff, and L.L. Iversen The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist Proc. Natl. Acad. Sci. U. S. A. 83 1986 7104 7108
89. J.T. Wroblewski, and W. Danysz Modulation of glutamate receptors: molecular mechanisms and functional implications Ann. Rev. Pharmacol. Toxicol. 29 1989 441 447
90. T. Zhang, Y.Z. Feng, R.E. Rockhold, and I.K. Ho Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat Life Sci. 55 1994 25 31
91. H. Zhu, and G.A. Barr Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists Psychopharmacology 150 2000 325 336
92. H. Zhu, and G.A. Barr Opiate withdrawal during development: are NMDA receptors indispensable? Trends Pharmacol. Sci. 22 2001 404 408
93. H. Zhu, and G.A. Barr Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age dependent Synapse 40 2001 282 293
94. H. Zhu, and I.K. Ho NMDA-R1 antisense oligonucleotide attenuates withdrawal signs from morphine Eur. J. Pharmacol. 352 1998 151 156
95. H. Zhu, R.E. Rockhold, and I.K. Ho The role of glutamate in physical dependence on opioids J. Pharmacol. Sci. (Jpn. J. Pharmacol.) 76 1998 1 14
96. H. Zhu, C.-G. Jang, T. Ma, S. Oh, R.E. Rockhold, and I.K. Ho Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment Eur. J. Pharmacol. 365 1999 47 54